MAP2K3 and ovarian cancer: Kang et al., demonstrated that ectopic MKK3 drives paclitaxel resistance by inducing p-glycoprotein expression in Heya8 and Skov3ip1 cells, suggesting the involvement of MKK3-p38MAPK pathway activation in ovarian cancer drug resistance [19].